Future research in IPF should focus on understanding the mechanisms that drive immune cell differentiation into either profibrotic or reparative phenotypes within the lung microenvironment by identifying the molecular cues, such as cytokines, chemokines, and cell-surface receptors. Here, CD177 is linked to idiopathic pulmonary fibrosis.